A motion of censure against the European Commission led by Ursula von der Leyen was submitted on Thursday, June 26, by far-right member of the European Parliament Gheorghe Piperea, part of the ...

You can also apply for accelerator programmes that will help guide you through the early days of startup life, and some ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

Using the ProFoundry platform and Novartis' expertise, the partners will identify novel proteins and drug targets for cardiovascular disease.

Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...

They synergy of industry, academic institutions and state agencies fosters innovation and strengthens Ireland’s ...

The U.S. FDA informed two pharmaceutical companies that it must update its warning labels about potential risks associated ...

The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...

Labels for the Pfizer and Moderna shots, which already caution about myocarditis and pericarditis, will more strongly stress ...

Australia's vaccination rates against COVID and influenza are below ideal figures, but could a future innovation be able to ...

The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...